141 related articles for article (PubMed ID: 37137498)
1. Gene-Expression Profiling to Decipher Breast Cancer Inter- and Intratumor Heterogeneity.
Swarbrick A; Fernandez-Martinez A; Perou CM
Cold Spring Harb Perspect Med; 2024 Jan; 14(1):. PubMed ID: 37137498
[TBL] [Abstract][Full Text] [Related]
2. Intratumor heterogeneity of breast cancer detected by epialleles shows association with hypoxic microenvironment.
Wang Y; Zhang Y; Huang Y; Chen C; Zhang X; Xing Y; Gu Y; Zhang M; Cai L; Xu S; Sun B
Theranostics; 2021; 11(9):4403-4420. PubMed ID: 33754068
[No Abstract] [Full Text] [Related]
3. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Holm K; Hegardt C; Gunnarsson H; Fagerholm R; Strand C; Agnarsson BA; Kilpivaara O; Luts L; Heikkilä P; Aittomäki K; Blomqvist C; Loman N; Malmström P; Olsson H; Johannsson OT; Arason A; Nevanlinna H; Barkardottir RB; Borg A
Breast Cancer Res; 2010; 12(3):R42. PubMed ID: 20576095
[TBL] [Abstract][Full Text] [Related]
4. Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes.
Gatza ML; Kung HN; Blackwell KL; Dewhirst MW; Marks JR; Chi JT
Breast Cancer Res; 2011 Jun; 13(3):R62. PubMed ID: 21672245
[TBL] [Abstract][Full Text] [Related]
5. Tumoral heterogeneity of breast cancer.
Roulot A; Héquet D; Guinebretière JM; Vincent-Salomon A; Lerebours F; Dubot C; Rouzier R
Ann Biol Clin (Paris); 2016 Dec; 74(6):653-660. PubMed ID: 27848916
[TBL] [Abstract][Full Text] [Related]
6. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
[TBL] [Abstract][Full Text] [Related]
7. Intratumor heterogeneity index of breast carcinomas based on DNA methylation profiles.
Campoy EM; Branham MT; Mayorga LS; Roqué M
BMC Cancer; 2019 Apr; 19(1):328. PubMed ID: 30953488
[TBL] [Abstract][Full Text] [Related]
8. Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome.
Barry WT; Kernagis DN; Dressman HK; Griffis RJ; Hunter JD; Olson JA; Marks JR; Ginsburg GS; Marcom PK; Nevins JR; Geradts J; Datto MB
J Clin Oncol; 2010 May; 28(13):2198-206. PubMed ID: 20368555
[TBL] [Abstract][Full Text] [Related]
9. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
[TBL] [Abstract][Full Text] [Related]
10. A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival.
Jaber MI; Song B; Taylor C; Vaske CJ; Benz SC; Rabizadeh S; Soon-Shiong P; Szeto CW
Breast Cancer Res; 2020 Jan; 22(1):12. PubMed ID: 31992350
[TBL] [Abstract][Full Text] [Related]
11. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ
Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575
[TBL] [Abstract][Full Text] [Related]
12. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).
Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA
Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures.
Li J; Wu J; Han J
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672784
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations.
Januškevičienė I; Petrikaitė V
Life Sci; 2019 Dec; 239():117009. PubMed ID: 31669239
[TBL] [Abstract][Full Text] [Related]
15. Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
Zhu B; Tse LA; Wang D; Koka H; Zhang T; Abubakar M; Lee P; Wang F; Wu C; Tsang KH; Chan WC; Law SH; Li M; Li W; Wu S; Liu Z; Huang B; Zhang H; Tang E; Kan Z; Lee S; Park YH; Nam SJ; Wang M; Sun X; Jones K; Zhu B; Hutchinson A; Hicks B; Prokunina-Olsson L; Shi J; Garcia-Closas M; Chanock S; Yang XR
Breast Cancer Res; 2019 Dec; 21(1):147. PubMed ID: 31856876
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling in breast cancer.
Morris SR; Carey LA
Rev Endocr Metab Disord; 2007 Sep; 8(3):185-98. PubMed ID: 17464566
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.
Merlino G; Miodini P; Callari M; D'Aiuto F; Cappelletti V; Daidone MG
Mol Oncol; 2017 Oct; 11(10):1399-1412. PubMed ID: 28672102
[TBL] [Abstract][Full Text] [Related]
18. Molecular classification of breast cancer: what the pathologist needs to know.
Rakha EA; Green AR
Pathology; 2017 Feb; 49(2):111-119. PubMed ID: 28040199
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Tumor Microenvironment in Breast Cancer: Prognostic and Predictive Significance and Therapeutic Opportunities.
Domínguez-Cejudo MA; Gil-Torralvo A; Cejuela M; Molina-Pinelo S; Salvador Bofill J
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069096
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.
Wirapati P; Sotiriou C; Kunkel S; Farmer P; Pradervand S; Haibe-Kains B; Desmedt C; Ignatiadis M; Sengstag T; Schütz F; Goldstein DR; Piccart M; Delorenzi M
Breast Cancer Res; 2008; 10(4):R65. PubMed ID: 18662380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
